LATEST
'Surveillance Pricing' Comes Under Scrutiny✦King of Morocco defends ‘partnership’ with Spain after Ceuta migrant rush✦The two Santiagos: What a shepherd and a fisherman can teach us about leadership✦US stocks: US market posts weekly gains with earnings, inflation data on tap✦"Pee Wees: Confessions of a Hockey Parent", "The Stories of John Cheever"✦
Fri, Oct 9, 2026
Loading weather...
Markets

Raymond James Initiates Coverage of Kymera Therapeutics with Outperform Rating

Fintel reports that on October 9, 2026, Raymond James initiated coverage of Kymera Therapeutics (NASDAQGM:KYMR) with a O...

By Dhallo News · October 10, 2026 at 1:10 AM IST

Fintel reports that on October 9, 2026, Raymond James initiated coverage of Kymera Therapeutics (NASDAQGM:KYMR) with a Outperform recommendation. Prior to this rating action, the stock closed at $109.30 on October 8, 2026. Kymera Therapeutics has experienced a one-week price chan

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

'Surveillance Pricing' Comes Under Scrutiny

Bloomberg's Max Chafkin, David Gura, and Jessica Karl join Scarlet Fu and Tom Ke...

Read Article »

"Pee Wees: Confessions of a Hockey Parent", "The Stories of John Cheever"

Bloomberg's Scarlet Fu and Tom Keene discuss their must-read book on this week's...

Read Article »

Soybeans Fading Lower as USDA Raises Production and Stocks

Soybeans are falling 12 to 13 cents across the front months on Friday, with spil...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.